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Abstract
Background: The increased frequency of laparoscopic hepatic resection as a principal or adjunct
component of patient care has driven the need for and development of efficient and safe hepatic
parenchymal transection technologies. At present, various devices are available for pre-coagulation
transection (PCT) of hepatic parenchyma with the intent of minimizing procedure-associated postopera-
tive haemorrhage and bile leak. This report presents the evaluation of a novel bipolar radiofrequency (RF)
energy device for PCT used for laparoscopic hepatic resection.
Methods: Patients undergoing laparoscopic hepatic resection using the Enseal™ device (SurgRx Inc.)
were identified from the prospectively maintained hepatobiliary database. Information on patient demo-
graphics, procedures and postoperative complications was collected and analysed; complications were
grouped into early (at <30 days) and late (at 30 days) events.
Results: A total of 18 patients, of whom 13 had malignant tumours (12 colorectal metastases and one
hepatocellular carcinoma) and five had benign tumours (two hepatic adenomas and three haemangiomas)
underwent 18 hepatic procedures, including two formal hemi-hepatectomies, four left lateral sections,
three posterior sections and nine atypical non-anatomic resections. Estimated blood loss did not differ
from institutional historical control data; no postoperative haemorrhage, bile leaks or hepatic abscess or
necrosis were identified (n = 18).
Conclusions: This initial experience using the laparoscopic bipolar RF device demonstrates an accept-
able safety profile in terms of the outcomes analysed.
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Introduction
The rapid increase in the frequency with which laparoscopic hepa-
tectomy is performed since its advent in the late 1990s has occurred
without a consensus on‘standard’ technique or instrumentation. It
is clear, however, that varied forms of thermal energy derived from
monopolar, bipolar, harmonic resonance and even microwave gen-
erators have been utilized and described as potential adjuncts to
staplers or mini-laparotomy during laparoscopic hepatic resection.
The Enseal™ device (SurgRx Inc., Redwood City, CA, USA)
employs bipolar radiofrequency (RF) energy and is approved as a
tissue cutting and sealing device for use during traditional open or
laparoscopic procedures.1 To date, no studies defining the role of
this device in hepatic resection have been published, although
several limited studies have reported the properties of the device
in various other surgical domains. The most salient demonstrated
capacities of the bipolar RF device include the sealing of blood
vessels in the range of 1–7 mm3 and a minimal (<1 mm) lateral
thermal spread of energy.
We present a series of patients who underwent laparoscopic
hepatectomy using the Enseal™ device and describe our clinical
This study was presented in part at the Eighth World Congress of the Inter-
national Hepato-Pancreato-Biliary Association, Mumbai, India, February
2008
DOI:10.1111/j.1477-2574.2009.00026.x HPB
HPB 2009, 11, 145–149 © 2009 International Hepato-Pancreato-Biliary Association
experience as a formal hepato-pancreato-biliary (HPB) team at a
volume centre for laparoscopic hepatic resection.
Materials and methods
Patients undergoing laparoscopic hepatic resection using the
bipolar RF device were identified from the prospectively main-
tained hepatobiliary database. Patient demographics, procedures
and postoperative complications were collected and analysed;
complications were grouped into early (at <30 days) and late (at
30 days) events.
Results
Eighteen consecutive patients (12 female, six male; mean age 50
years) undergoing planned laparoscopic hepatic resection for
benign or malignant tumours were resected using the bipolar RF
device for pre-coagulation transection (PCT).
For formal hemi-hepatectomy, lateral or posterior sections, the
hepatic portal pedicles (using the pedicle isolation technique
described by Cunningham et al.,2 modified to laparoscopy)
and/or hepatic veins were divided with an endomechanical sta-
pling device (EndoGIA™; Covidien Corp., Norwalk, CT, USA)
after PCT. In this cohort, the procedures performed included two
formal hemi-hepatectomies, four left lateral sections, three poste-
rior sections and nine atypical non-anatomic resections (defined
as resections that do not respect anatomic boundaries of
Couinaud liver segmentation and include subsegmentectomies, or
resection of more than one segment). Twelve of the 18 patients
underwent concomitant surgical procedures as follows: RF abla-
tion of other liver lesions (n = 9); partial colon resection (n = 2),
and reversal of Hartman’s procedure (n = 1). Mean estimated
blood loss per procedure was 178 ml 53 ml (Table 1). Estimated
blood loss did not differ from institutional historical control. No
patient required blood transfusion, and no postoperative haem-
orrhage (defined as haemodynamic instability, drop in haemoglo-
bin >2 mg/dl or postoperative haematoma requiring surgical or
interventional radiology drainage) or bile leaks were identified in
the <30-day or 30-day postoperative periods. Additionally, no
resection plane parenchymal necrosis or hepatic abscess was noted
on routine 30-day postoperative imaging, although this has been
previously described with other energy-based PCT devices.
The bipolar RF device
The bipolar RF device allows surgeons to seal and transect small to
large vessels and tissue bundles to achieve surgical haemostasis.
We used the 5-mm-diameter laparoscopic bipolar RF instrument.
According to the published literature, this device has the capacity
to seal vessels of 1–7 mm in diameter and the seal created has
been demonstrated to withstand over seven times normal systolic
pressure.3
Table 1 Patient demographics, liver pathology, estimated blood loss and total surgical time
Patient Age,
years




1 66 F CRM Non-anatomic resection RFA 100 60
2 57 M CRM Non-anatomic resection None 100 70
3 68 M CRM Left lateral RFA 180 120
4 54 F CRM Left hepatectomy Hartman's reversal 200 300
5 46 F CRM Non-anatomic resection Colon resection 250 180
6 52 F CRM Posterior sectorectomy RFA 200 150
7 48 M CRM Left lateral RFA 220 160
8 55 M CRM Right hepatectomy RFA 250 200
9 47 F CRM Left lateral Colon resection 200 170
10 65 F CRM Non-anatomic resection RFA 150 120
11 51 M CRM Non-anatomic resection RFA 50 180
12 53 F CRM Posterior sectorectomy RFA 200 170
13 43 F HCC Posterior sectorectomy None 200 120
14 47 F Haemangioma Non-anatomic resection None 200 100
15 40 F Haemangioma Left lateral None 200 110
16 51 M Haemangioma Non-anatomic resection None 150 120
17 28 F Adenoma Non-anatomic resection RFA 200 120
18 35 F Adenoma Non-anatomic resection None 150 90
50  10* 12 F
6 M
12 concomitant surgery 178  53* 114  56*
*Average  standard deviation
F, female; M, male; CRM, colorectal metastasis; RFA, radiofrequency ablation; HCC, hepatocellular carcinoma
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Bipolar RF energy delivery in tissue occurs under the ‘line of
sight’ principle, where energy is transferred only between the
electrodes, or in this case, between the jaws of the device. As such,
current flow and heat deposition are confined only to tissue held
within the jaws of the instrument. An advantage of this approach
is that lateral thermal spread is minimized.
For laparoscopic liver surgery, the 535 RH model was selected
because it has a rounded tip, which allows soft atraumatic intro-
duction into the hepatic parenchyma, and a 35-cm shaft length,
which allows for comfortable handling and is sufficient to reach
any target point on the liver.
Technique
Without inflow occlusion and under low central venous pressure
(CVP) (<5 mmHg), the hepatic lesion is identified, guided by
intraoperative ultrasound (IOUS), and the liver capsule is scored
1 cm away from the lesion borders, using a monopolar elec-
trocautery device. The scoring is used as guide for the parenchy-
mal transection, with further application of the IOUS as needed
to assure an adequate margin. The bipolar RF device is then
introduced into the parenchyma with the straight inferior blade
penetrating the parenchyma. The jaws of the device are closed to
compress the parenchyma without crushing. The device is acti-
vated (by either a pull trigger or a foot pedal); PCT begins and
as the coagulation progresses with concomitant tissue desicca-
tion, the jaws allow the deployment of an ‘I’ cutting beam in a
manner similar to that of an endomechanical stapler. In our
experience, each closure of the device, which represents a PCT of
a 1-cm segment of parenchyma, takes 3–10 sec to perform. The
variability is dependent on how thick a portion of tissue is
grasped. As the energy delivery cycle propagates coagulation,
‘time-out’ impedance is reached and energy delivery ceases. The
device cutting tip length is approximately 20 mm and, using
sequential forward advancement, a PCT plane is achieved. After
each cycle, the superior jaw is opened as soon as the transection
is completed and the straight jaw is advanced into the liver
parenchyma following the tract initiated and guided by the lines
scored on the liver capsule. It is important to keep the straight
jaw at the same level of depth and advance it gradually to obtain
a uniform, consistent and rapid PCT plane. The 360-degree
rotation capability of the device allows it to advance forwards
without applying torque on the liver parenchyma, thus avoiding
small parenchymal fractures.
The PCT plane is defined in an inferior (edge of the cystic fossa)
to superior direction in the case of formal hepatectomy, or in a
lateral to medial fashion in atypical resections. In our approach,
the device is used for the first 2 cm of the circumference of the
liver parenchyma as the parenchyma is divided, bridging or reveal-
ing hepatic veins, and endomechanical staplers are used to divide
these particular structures. Thus, the objectives of the laborious
procedures involved in the ‘crush–clamp’ technique for parenchy-
mal transection can be accomplished without the need for ligature
or clips.
Discussion
The resection rate of benign and malignant hepatic tumours
has increased over the last decade and continues to do so.
Various factors have contributed to this, including greater
availability of hepatobiliary training, increased quality and
frequency of body imaging, the refinement of operative tech-
niques and the development of novel devices to facilitate
hepatic parenchymal transection procedures. Laparoscopy and
hepatic surgery have rapidly merged, with the result that laparo-
scopic hepatic resection as a principal or adjunct component of
patient care is fairly common, even outwith major tertiary care
centres.
Laparoscopic liver resection is inherently challenging on several
fronts, but the fact that it precludes conventional blood vessel and
bile duct ligation represents a key deterrent. Accordingly, tech-
niques and technologies have been developed to overcome this
limitation. Energy-based devices that are intended to allow for the
simultaneous sealing, coagulating and cutting of blood vessels are
used in preference to performing these procedures mechanically
by tying, suturing, clipping or stapling, with the intention of mini-
mizing procedure-associated morbidity such as postoperative
haemorrhage and bile leak. However, the optimal device for these
purposes has yet to be established.
Pre-coagulation transection is the term used to cover a broad
use of energy devices in hepatic resection, whether by laparotomy
or laparoscopy.4 The PCT process is based on the response of
hepatic parenchyma to thermal energy, most commonly monopo-
lar, but, more recently, bipolar RF energy. Parenchymal protein
denaturation occurs at high temperatures,5 with resultant blood
vessel wall and bile duct fusion, which translates into more con-
trolled operative bleeding and potentially decreased postoperative
haemorrhage or bile leak.
In the present series, 18 patients underwent laparoscopic
hepatic resection procedures ranging from formal hemi-
hepatectomy to atypical resection. The bipolar RF energy device
was primarily utilized for PCT in a similar fashion to the crush–
clamp technique. During PCT, minimal tissue charring on the
active jaws of the device was observed, allowing for the sequential
linear application of energy along a planned transection plane.
The particular bipolar device employed provided efficient laparo-
scopic PCT in a smokeless field, thereby ensuring a continuous
clear operative field and eliminating the smoke evacuation and
cleaning of optical equipment that are required by other paren-
chymal transection systems.
The device was already in use in our institution for various
other laparoscopic surgical procedures (i.e. colon-related and
oesophageal procedures) and thus we did not need to climb a
learning curve to expand its use for PCT of liver parenchyma.
However, in recognition of the fragile character of liver paren-
chyma, we encouraged a consistent and slow transection tech-
nique to avoid the crushing or tearing of non-precoagulated
tissues.
HPB 147
HPB 2009, 11, 145–149 © 2009 International Hepato-Pancreato-Biliary Association
The subjective observations of the operating team included a
comment that parenchymal haemostasis was excellent. There was
no difference in estimated blood loss between the first patients and
the rest of the patient group. No transfusions were required and no
major postoperative haemorrhage was observed; however, this is
more likely to reflect our strict adherence to the low CVP anaes-
thetic technique and the fact that our operating surgeons were
senior, experienced and HPB-focused. There was also no clinical
evidence of bile leak; to date there is no experimental or clinical
study demonstrating the effectiveness of the bipolar RF device
specifically for bile duct sealing. We note that it is possible that
clinically insignificant bile leaks may have occurred,but it is not our
standard practice to employ drains. Nonetheless, no patient in the
series required an intervention for bile leak. In recognition of our
numerically modest cohort, we make no observations on compli-
cations arising <30 days or30 days post-surgery.
This bipolar RF device is about 2 cm in length at the functional
portion of the head, which is comprised of jaws. The head is
designed to facilitate atraumatic dissection. The device has been
approved by the US Food & Drug Administration for tissue
sealing and several experimental studies have further character-
ized its properties. In a recent technology-comparative study,
vessel burst pressures with this bipolar RF device were reported to
be significantly higher than those of four other energy-based
instruments. Interestingly, on histopathological analysis, the
bipolar RF device demonstrated that porcine vessels sealed in vivo
exhibited less radial adventitial collagen denaturation compared
with those sealed by other similar devices.3
In further experimental support of the observation that
decreased lateral thermal energy spread results in fewer potential
tissue complications, a comparison among the bipolar RF device,
a competitive vessel sealer and in vivo suturing on rat liver paren-
chyma demonstrated that necrosis, exudate formation, chronic
inflammation, histiocyte and fibroblast scores were significantly
lower in the bipolar RF group compared with the competitive
vessel sealer and suture groups.5 Bipolar RF was superior to both
the competitive vessel sealer and to suturing in that it achieved a
reduced inflammatory response, which is probably secondary to
decreased lateral thermal injury and inflammatory response.5 In a
separate experimental study evaluating the effects of adhesion
formation secondary to use of the bipolar RF device, the authors
reported significantly lower adhesion formation in the bipolar RF
device group compared with groups in which other energy-based
vessel-sealing devices or suturing were used.6
The incentive to minimize lateral thermal spread in laparo-
scopic surgery is largely based on the need to prevent inadvertent
tissue injury. Although this represents a positive feature for non-
hepatic applications, the device has been criticized for failing to
attain a wider ablation in the plane of resection, which some
authors have proposed as desirable for malignant lesions.7 A sepa-
rate, but important, limitation of the technology concerns the
width of the jaw aperture, which limits the amount of tissue that
can be grasped for PCT.
We acknowledge that this study has limitations. It is difficult to
estimate a potential benefit in limiting blood loss with the use of
the device in our series for the following reasons: most of the cases
included in this series involved combined surgical procedures
where liver resections were concomitant with various other pro-
cedures (RF ablation, colon resection, Hartman’s reversal) with an
inherently wide range of potential blood loss. It would be unreal-
istic to construct a comparative study with a similar group of
patients undergoing similar combined surgical procedures. Esti-
mated blood loss is, by definition, estimated and thus subjective,
and potential differences between different modalities can only by
established by analysing a very large group of patients.
In order to evaluate the haemostatic role of the device in our
study, we used objective data such as those pertaining to need for
blood transfusion, haemodynamic instability, major decreases in
haemoglobin (of >2 units) and postoperative haematoma requir-
ing surgical or interventional radiology drainage.
It is difficult to compare the other beneficial aspects of this
device with those of other devices, although its capabilities are
very much appreciated. These parameters would include the
absence of torque force within the parenchyma in conjunction
with its 360-degree rotation capability, the fact that it allows for a
smokeless surgical field during laparoscopy, and its inherent ease
of use. In the present series, these beneficial effects are reported in
terms of the absence of objective negative outcome parameters,
rather than as beneficial effects: thus we note that no blood trans-
fusion was required in any of our cases, and no postoperative
haematoma, bile leak, abscesses or liver necrosis were observed.
For the reasons cited above, our study was not constructed to
compare outcomes with this device with those of other similar
devices by measuring estimated blood loss; consequently, the
study does not claim that this device is superior to other sealing or
haemostatic products. Rather, the goal of our study was to dem-
onstrate the safety of using this device and to better define its
application as an adjunct to laparoscopic hepatic surgery.
Our clinical experience with the bipolar RF device presented
here demonstrates an acceptable safety and performance profile
for its use in PCT for laparoscopic hepatic resection. The effect(s)
of this device in cirrhotic liver have not been defined or addressed
in the present report. The device can be used to transect liver
without any inflow occlusion, which should be seen as an advan-
tage that supports its inclusion in the armamentarium of technol-
ogy available for use in laparoscopic liver resection.
The field of laparoscopic hepatectomy is in evolution and con-
sensus is lacking about optimal instrumentation and technique. A
wide array of devices and techniques for hepatic parenchymal
transection have been reported by different teams and institu-
tions. At present, laparoscopic hepatic surgeons should aim to
define the technologies and techniques that are safe, as well as
useful. The present series is the first to report the safety and
efficacy of PCT of liver parenchyma using bipolar RF technology
provided by the Enseal™ device. Further studies with multi-
institutional collaboration may be useful to evaluate the various
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devices and techniques appropriate for these procedures, although
it is unlikely than any single approach will emerge as superior to
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